FDA approvaloutcome: successconf 1.00
cabometyx — FDA approval
$EXEL · EXELIXIS, INC.
Event date
September 10, 2025
269 days ago
Sponsor runway
cash-flow +
$777.2M liquid
Evidence
Comparable historical fda approvals· last 5 years · same event type
100% hit rate (10/10)
| Ticker | Drug | Date | Outcome |
|---|---|---|---|
| $INCY | zynyz | 2026-05-18 | success |
| $INCY | jakafi xr | 2026-05-01 | success |
| $AXSM | auvelity | 2026-04-30 | success |
| $INCY | zynyz | 2026-03-30 | success |
| $BIIB | spinraza | 2026-03-27 | success |
| $CORT | lifyorli | 2026-03-25 | success |
| $RYTM | imcivree | 2026-03-19 | success |
| $ASND | yuviwel | 2026-02-27 | success |
| $BMRN | palynziq | 2026-02-27 | success |
| $ETON | desmoda | 2026-02-25 | success |
Recent insider activity· ±90 days
8 insiders · 1 buys · 8 sells
Grant
2025-12-03Hefti Brenda
SVP and General Counsel
30,170 @ ——
Buy
2025-11-25JOHNSON DAVID EDWARD
Director
27,532 @ $43.12$1.19M
Gift
2025-11-21Aftab Dana
EVP, Research and Development
24,000 @ ——
Sell
2025-11-21Haley Patrick J.
EVP, Commercial
28,043 @ $42.58$1.19M
Sell
2025-11-20Haley Patrick J.
EVP, Commercial
10,000 @ $42.11$421K
Sell
2025-11-20Haley Patrick J.
EVP, Commercial
10,648 @ $41.77$445K
Sell
2025-11-20Haley Patrick J.
EVP, Commercial
23,539 @ $41.93$987K
Gift
2025-11-17Oliver Bob
Director
1,044 @ ——
Gift
2025-11-12MORRISSEY MICHAEL
President and CEO
101,548 @ ——
Sell
2025-11-12PAPADOPOULOS STELIOS
Director
100,000 @ $43.55$4.36M
Gift
2025-11-12MORRISSEY MICHAEL
President and CEO
80,000 @ ——
Gift
2025-11-11MORRISSEY MICHAEL
President and CEO
160,000 @ ——
Sell
2025-11-11Beckerle Mary C
Director
18,838 @ $41.90$789K
Exercise
2025-11-11Beckerle Mary C
Director
5,784 @ $23.24$134K
Sell
2025-11-11Beckerle Mary C
Director
5,784 @ $42.03$243K
Sell
2025-11-11Aftab Dana
EVP, Research and Development
48,383 @ $42.50$2.06M
Grant
2025-10-08Aftab Dana
EVP, Research and Development
50,673 @ ——